|
1 / 1
|
DeCS
|
|
 |
|
Descriptor English:
|
|
Clinical Trials, Phase III as Topic
|
|
Descriptor Spanish:
|
|
ensayos clínicos en fase III como asunto
|
|
Descriptor Portuguese:
|
|
Ensaios Clínicos Fase III como Assunto
|
|
Synonyms English:
|
|
Clinical Trials, Phase 3 as Topic
Drug Evaluation, FDA Phase 3 as Topic
Drug Evaluation, FDA Phase III as Topic
Evaluation Studies, FDA Phase 3 as Topic
Evaluation Studies, FDA Phase III as Topic
|
|
Tree Number:
|
|
E05.318.372.250.250.220
N05.715.360.330.250.250.220
N06.850.520.450.250.250.220
VS2.002.003.001.003.003
|
|
Definition English:
|
|
Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries. |
|
Indexing Annotation English:
|
|
for general design, methodology, economics, etc. of phase III clinical trials; a different heading CLINICAL TRIAL, PHASE III is used for reports of a specific phase III clinical trial
|
|
History Note English:
|
|
2008(1993)
|
|
Allowable Qualifiers English:
|
|
|
|
Record Number:
|
|
30782
|
|
Unique Identifier:
|
|
D017326
|
Occurrence in VHL:
|
|
|
Similar:
|
|
DeCS
|